The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase II study of nivolumab (N) alone versus with pegilodecakin (PEG) in combination with N in patients (pts) with post-platinum immunotherapy-naive stage IV non-small cell lung cancer (NSCLC) and no or low PD-L1 expression (CYPRESS 2).
 
Robert M. Jotte
Honoraria - Bristol-Myers Squibb; Roche/Genentech
Speakers' Bureau - Bristol-Myers Squibb; Roche/Genentech
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche/Genentech
 
Jerome H. Goldschmidt
No Relationships to Disclose
 
Jeffrey Gary Schneider
Stock and Other Ownership Interests - Arvinas; Bristol-Myers Squibb; GlaxoSmithKline; Mirati Therapeutics; Novartis; Pfizer
Honoraria - Foundation Medicine
 
Merrill Kingman Shum
No Relationships to Disclose
 
David Berz
Honoraria - AstraZeneca; Genentech; Sun Pharma; Tempus
Speakers' Bureau - AstraZeneca; Biocept; Boehringer Ingelheim; Caris Life Sciences; Genentech; natera; Novartis; Sun Pharma; Tempus
 
Lasika C. Seneviratne
Consulting or Advisory Role - Novartis Pharmaceuticals UK Ltd.
Speakers' Bureau - Novartis Pharmaceuticals UK Ltd.
Travel, Accommodations, Expenses - Novartis Pharmaceuticals UK Ltd.
 
Matei P. Socoteanu
Employment - Texas Oncology; Texas Oncology
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Genentech (Inst); Lilly (Inst); Lilly (Inst); Merck (Inst); Merck (Inst); Seagen (Inst); Seagen (Inst)
 
Annie Hung
Employment - ARMO BioSciences; Lilly
Stock and Other Ownership Interests - ARMO BioSciences; Lilly
 
Rebecca R. Hozak
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Patents, Royalties, Other Intellectual Property - Patent published and pending related to ramucirumab.
 
Bo H. Chao
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
John J. Nemunaitis
Employment - Gradalis
Leadership - Gradalis
Stock and Other Ownership Interests - Gradalis
Honoraria - AstraZeneca
Consulting or Advisory Role - SymVivo
Speakers' Bureau - AstraZeneca
Patents, Royalties, Other Intellectual Property - Gradalis
Expert Testimony - Foundation Medicine